drugset / Trial / NCT07466030

Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate

NCT07466030

Phase 1 Not yet recruiting 40 enrolled Assiut University
RandomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the impact of daily tadalafil 5 mg on storage lower urinary tract symptoms (LUTS) during the early postoperative period following Anatomical endoscopic enucleation of prostate in a randomized controlled clinical trial.

Timeline

Start
2026-03-01
Primary completion
2028-03-01
Completion
2028-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 5 mg Oral